細胞治療の世界市場レポート 2025

細胞治療市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.5％で292億8,000万米ドルに成長します。予測期間の成長は、倫理的・社会的配慮、投資・資金動向、消費者・患者の需要、ヘルスケアインフラ、急速なイノベーションサイクルに起因すると考えられます。予測期間の主な動向には、個別化医療、新たな標的治療、遺伝子編集技術、幹細胞研究の拡大、免疫療法の進歩、微小環境操作などが含まれます。

慢性疾患の増加は細胞治療市場の成長を促進しています。米国疾病予防管理センター（CDC）によると、慢性疾患とは、1年以上持続し、医師の治療を必要とし、日常生活が制限され、またはその両方を伴う状態を指し、心臓病、がん、糖尿病、パーキンソン病などの病気が含まれます。幹細胞は、脊髄損傷、1型糖尿病、パーキンソン病（PD）、心臓病、がん、変形性関節症など、さまざまな症状に苦しむ患者に恩恵をもたらすことができます。例えば、2024年7月、CDCは公衆衛生の取り組みに関する重要な最新情報を報告しました。毎年、94万4,800人以上のアメリカ人が心臓病や脳卒中で死亡しており、これは死亡者全体の3分の1以上を占めています。米国では、毎年170万人ががんと診断され、60万人以上が死亡し、死因の第2位となっています。さらに、3,800万人以上のアメリカ人が糖尿病を患っており、さらに9,800万人の成人が糖尿病予備軍であり、2型糖尿病の発症リスクを高めています。糖尿病は、心臓病、腎不全、失明などの深刻な合併症を引き起こす可能性があります。さらに、肥満は子どもの20％、成人の42％を占め、2型糖尿病、心臓病、特定のがんなどの慢性疾患のリスクを高めています。慢性疾患の有病率の上昇は細胞治療への需要を高め、細胞治療市場の拡大に寄与しています。

投資の増加は、細胞治療市場の今後の成長を促進すると予想されます。細胞治療への投資とは、細胞ベースの治療法の研究、開発、製造、商業化を支援することを目的とした財源、資本、資金の配分を指します。このような投資は、細胞治療の新製品や新技術の研究開発、またこれらの製品を評価する臨床試験の実施に活用され、細胞療法を強化・改善します。例えば、2023年、英国を拠点とするライフサイエンスおよびバイオテクノロジー業界を代表する組織であるバイオインダストリー協会（BIA）は、英国の細胞・遺伝子治療企業が、欧州企業が獲得したベンチャーキャピタル資金の55％以上を確保したと報告しています。英国は一般的に、ライフ・サイエンス分野への欧州のベンチャー・キャピタル投資の約3分の1を占めており、その細胞・遺伝子治療分野の強さを物語っています。これとは対照的に、米国企業は2022年に細胞・遺伝子治療のベンチャー資金調達の86％を獲得しており、2023年には海外企業を上回ることが予想されます。このように、投資の増加が細胞治療市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界細胞治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の細胞治療市場：成長率分析
• 世界の細胞治療市場の実績：規模と成長, 2019-2024
• 世界の細胞治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界細胞治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の細胞治療市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ステム細胞治療
• 細胞ワクチン
• 養子細胞移植（ACT）
• 線維芽細胞細胞治療
• 軟骨細胞細胞治療
• 世界の細胞治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 同種療法
• 自家療法
• 世界の細胞治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 心血管疾患（CVD）
• 整形外科
• 傷の治癒
• その他の用途
• 世界の細胞治療市場幹細胞療法の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 造血幹細胞移植
• 間葉系幹細胞治療
• 胚性幹細胞治療
• 人工多能性幹細胞細胞治療
• 世界の細胞治療市場細胞ワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 樹状細胞ワクチン
• 腫瘍浸潤リンパ球（TIL）ワクチン
• 抗原特異的細胞ワクチン
• 世界の細胞治療市場、養子細胞移植（ACT）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CAR T細胞療法
• T細胞受容体（TCR）療法
• ナチュラルキラー（NK）細胞治療
• 世界の細胞治療市場線維芽細胞療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 真皮線維芽細胞療法
• 脂肪由来幹細胞細胞治療
• 世界の細胞治療市場軟骨細胞療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自家軟骨細胞移植（ACI）
• 軟骨移植療法

第7章 地域別・国別分析

• 世界の細胞治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の細胞治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞治療市場：競合情勢
• 細胞治療市場：企業プロファイル
  • Celgene Corporation Overview, Products and Services, Strategy and Financial Analysis
  • JCR Pharmaceuticals Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Baxter Healthcare Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Nipro Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Stempeutics Research Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Osiris Therapeutics Inc.
• Vericel Corporation
• AlloSource
• Anterogen Co. Ltd.
• Arteriocyte Medical Systems Inc.
• MediPost Co. Ltd.
• Pharmicell Co. Ltd.
• Corestem Inc.
• Stemedica Cell Technologies Inc.
• Adaptimmune Therapeutics plc
• Mesoblast Ltd.
• Cell Medica Ltd.
• Cellerant Therapeutics Inc.
• Kolon TissueGene Inc.
• Tego Science Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 細胞治療市場2029：新たな機会を提供する国
• 細胞治療市場2029：新たな機会を提供するセグメント
• 細胞治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cell therapy involves the replacement or repair of damaged tissue and/or cells by transplanting human cells. Various types of cells can be employed as part of a therapy or treatment for a range of diseases and disorders, leveraging new technologies, innovative products, and boundless imagination. This treatment form entails the administration of live cells to patients through injection, grafting, or implantation to achieve a therapeutic outcome.

The primary techniques employed in cell therapy include stem cell therapy, cell vaccines, adoptive cell transfer (ACT), fibroblast cell therapy, and chondrocyte cell therapy. Stem cell treatment, also recognized as regenerative medicine, utilizes stem cells or their derivatives to stimulate the healing response in diseased, defective, or injured tissues. Allogeneic therapies and autologous therapies are the two main types of therapies used in various applications such as oncology, cardiovascular disease (CVD), orthopedics, wound healing, and more.

The cell therapy market research report is one of a series of new reports from The Business Research Company that provides cell therapy market statistics, including cell therapy industry global market size, regional shares, competitors with a cell therapy market share, detailed cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy industry. This cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell therapy market size has grown rapidly in recent years. It will grow from $14.56 billion in 2024 to $17.02 billion in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to early research and discoveries, regulatory milestones, clinical trials and studies, early adopters and pioneering companies, market acceptance and perception.

The cell therapy market size is expected to see rapid growth in the next few years. It will grow to $29.28 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to ethical and societal considerations, investment and funding trends, consumer/patient demand, healthcare infrastructure, rapid innovation cycles. Major trends in the forecast period include personalized medicine, emerging targeted treatments, gene editing technologies, stem cell research expansion, immunotherapy advancements, microenvironment manipulation.

The increasing prevalence of chronic diseases has facilitated the growth of the cell therapy market. According to the US Centers for Disease Control and Prevention (CDC), chronic diseases are conditions that persist for a year or more, require medical attention, limit daily activities, or both, and include illnesses such as heart disease, cancer, diabetes, and Parkinson's disease. Stem cells can provide benefits to patients suffering from various conditions, including spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis. For example, in July 2024, the CDC reported significant updates regarding public health initiatives. Each year, over 944,800 Americans die from heart disease or stroke, which accounts for more than one-third of all deaths. In the U.S., 1.7 million individuals are diagnosed with cancer annually, resulting in over 600,000 deaths, making it the second leading cause of death. Additionally, more than 38 million Americans have diabetes, and another 98 million adults are prediabetic, increasing their risk of developing type 2 diabetes. Diabetes can lead to serious complications such as heart disease, kidney failure, and blindness. Furthermore, obesity affects 20% of children and 42% of adults, heightening the risk of chronic diseases like type 2 diabetes, heart disease, and certain cancers. The rising prevalence of chronic diseases has heightened the demand for cell therapies, contributing to the expansion of the cell therapy market.

Increasing investments are anticipated to drive the growth of the cell therapy market in the future. Investment in cell therapy refers to the allocation of financial resources, capital, or funding aimed at supporting the research, development, manufacturing, and commercialization of cell-based therapies. Such investments are being utilized to further research and develop new cell therapy products and technologies, as well as to conduct clinical trials evaluating these products, which will enhance and improve cell therapies. For instance, in 2023, the BioIndustry Association (BIA), a UK-based organization representing the life sciences and biotech industry, reported that UK cell and gene therapy companies secured over 55% of the venture capital funding obtained by European firms. The UK generally accounts for around one-third of all European venture capital investments in life sciences, underscoring the strength of its cell and gene therapy sector. In contrast, US companies captured 86% of the venture funding for cell and gene therapies in 2022 and are expected to outpace their international counterparts in 2023. Thus, rising investment is fueling the growth of the cell therapy market.

Key market players are strategically forming partnerships and collaborations to enhance their product portfolios and expand their geographical reach. In November 2023, Ajinomoto Co Inc., a Japan-based food company, acquired Forge Biologics for $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.'s global capabilities in AAV and plasmid gene therapy manufacturing, thereby enriching and reinforcing its existing contract development and manufacturing services. Forge Biologics is a US-based biotechnology company dedicated to advancing cell therapy technologies for various diseases.

Leading companies in the cell therapy market are pursuing strategic partnerships to deliver innovative and effective therapies to patients. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For instance, in September 2022, Genentech Inc., a US biotechnology corporation, entered into a partnership with Arsenal Biosciences, Inc., a US-based programmable cell therapy company. This collaboration aims to expedite the development of next-generation cell therapy products, potentially leading to new and more effective therapies for solid tumors-a significant breakthrough for cancer patients. Both companies are committed to investing in new technologies and delivering innovative treatments to those affected by cancer.

In August 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Sigilon Therapeutics for $34.6 million. This acquisition aims to bolster Lilly's research and development efforts in encapsulated cell therapies, specifically focusing on Type 1 diabetes with its lead candidate, SIG-002. This strategic move will enhance Lilly's position in the diabetes treatment market. Sigilon Therapeutics is a US-based biotechnology company concentrating on the development of innovative cell therapies.

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell therapy market includes revenues earned by entities by enhancing the growth of new healthy skin tissue and enhancing collagen production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technique: Stem Cell Therapy; Cell Vaccine; Adoptive Cell Transfer (ACT); Fibroblast Cell Therapy; Chondrocyte Cell Therapy
• 2) By Therapy Type: Allogeneic Therapies; Autologous Therapies
• 3) By Application: Oncology; Cardiovascular Disease (CVD); Orthopedic; Wound Healing; Other Applications
• Subsegments:
• 1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation; Mesenchymal Stem Cell Therapy; Embryonic Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy
• 2) By Cell Vaccine: Dendritic Cell Vaccine; Tumor-Infiltrating Lymphocyte (TIL) Vaccine; Antigen-Specific Cell Vaccine
• 3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy; T-Cell Receptor (TCR) Therapy; Natural Killer (NK) Cell Therapy
• 4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy; Adipose-Derived Stem Cell Therapy
• 5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI); Chondral Graft Therapy
• Companies Mentioned: Celgene Corporation; JCR Pharmaceuticals Co. Ltd.; Baxter Healthcare Corporation; Nipro Corp.; Stempeutics Research Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Therapy Market Characteristics

3. Cell Therapy Market Trends And Strategies

4. Cell Therapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cell Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell Therapy Market Growth Rate Analysis
• 5.4. Global Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell Therapy Total Addressable Market (TAM)

6. Cell Therapy Market Segmentation

• 6.1. Global Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Therapy
• Cell Vaccine
• Adoptive Cell Transfer (ACT)
• Fibroblast Cell Therapy
• Chondrocyte Cell Therapy
• 6.2. Global Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allogeneic Therapies
• Autologous Therapies
• 6.3. Global Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiovascular Disease (CVD)
• Orthopedic
• Wound Healing
• Other Applications
• 6.4. Global Cell Therapy Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hematopoietic Stem Cell Transplantation
• Mesenchymal Stem Cell Therapy
• Embryonic Stem Cell Therapy
• Induced Pluripotent Stem Cell Therapy
• 6.5. Global Cell Therapy Market, Sub-Segmentation Of Cell Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dendritic Cell Vaccine
• Tumor-Infiltrating Lymphocyte (TIL) Vaccine
• Antigen-Specific Cell Vaccine
• 6.6. Global Cell Therapy Market, Sub-Segmentation Of Adoptive Cell Transfer (ACT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CAR T-Cell Therapy
• T-Cell Receptor (TCR) Therapy
• Natural Killer (NK) Cell Therapy
• 6.7. Global Cell Therapy Market, Sub-Segmentation Of Fibroblast Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermal Fibroblast Therapy
• Adipose-Derived Stem Cell Therapy
• 6.8. Global Cell Therapy Market, Sub-Segmentation Of Chondrocyte Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Chondrocyte Implantation (ACI)
• Chondral Graft Therapy

7. Cell Therapy Market Regional And Country Analysis

• 7.1. Global Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Therapy Market

• 8.1. Asia-Pacific Cell Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Therapy Market

• 9.1. China Cell Therapy Market Overview
• 9.2. China Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Therapy Market

• 10.1. India Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Therapy Market

• 11.1. Japan Cell Therapy Market Overview
• 11.2. Japan Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Therapy Market

• 12.1. Australia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Therapy Market

• 13.1. Indonesia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Therapy Market

• 14.1. South Korea Cell Therapy Market Overview
• 14.2. South Korea Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Therapy Market

• 15.1. Western Europe Cell Therapy Market Overview
• 15.2. Western Europe Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Therapy Market

• 16.1. UK Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Therapy Market

• 17.1. Germany Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Therapy Market

• 18.1. France Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Therapy Market

• 19.1. Italy Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Therapy Market

• 20.1. Spain Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Therapy Market

• 21.1. Eastern Europe Cell Therapy Market Overview
• 21.2. Eastern Europe Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Therapy Market

• 22.1. Russia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Therapy Market

• 23.1. North America Cell Therapy Market Overview
• 23.2. North America Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Therapy Market

• 24.1. USA Cell Therapy Market Overview
• 24.2. USA Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Therapy Market

• 25.1. Canada Cell Therapy Market Overview
• 25.2. Canada Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Therapy Market

• 26.1. South America Cell Therapy Market Overview
• 26.2. South America Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Therapy Market

• 27.1. Brazil Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Therapy Market

• 28.1. Middle East Cell Therapy Market Overview
• 28.2. Middle East Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Therapy Market

• 29.1. Africa Cell Therapy Market Overview
• 29.2. Africa Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Therapy Market Competitive Landscape And Company Profiles

• 30.1. Cell Therapy Market Competitive Landscape
• 30.2. Cell Therapy Market Company Profiles
  • 30.2.1. Celgene Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. JCR Pharmaceuticals Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter Healthcare Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Nipro Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stempeutics Research Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Cell Therapy Market Other Major And Innovative Companies

• 31.1. Osiris Therapeutics Inc.
• 31.2. Vericel Corporation
• 31.3. AlloSource
• 31.4. Anterogen Co. Ltd.
• 31.5. Arteriocyte Medical Systems Inc.
• 31.6. MediPost Co. Ltd.
• 31.7. Pharmicell Co. Ltd.
• 31.8. Corestem Inc.
• 31.9. Stemedica Cell Technologies Inc.
• 31.10. Adaptimmune Therapeutics plc
• 31.11. Mesoblast Ltd.
• 31.12. Cell Medica Ltd.
• 31.13. Cellerant Therapeutics Inc.
• 31.14. Kolon TissueGene Inc.
• 31.15. Tego Science Inc.

32. Global Cell Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Therapy Market

34. Recent Developments In The Cell Therapy Market

35. Cell Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Cell Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer